Transaction DateRecipientSharesTypePriceValue
12th February 2021Ron Bentsur23,419Exercise of derivative$4.25$99,530.75
12th February 2021Ron Bentsur23,419Open or private sale$6.36$148,944.84
11th February 2021Ron Bentsur1,500Open or private sale$6.28$9,420.00
25th August 2020Ron Bentsur1,580Open or private sale$5.95$9,406.21
24th August 2020Ron Bentsur3,889Open or private sale$5.68$22,104.30
21st August 2020Ron Bentsur3,246Open or private sale$6.05$19,650.63
20th August 2020Ron Bentsur3,778Open or private sale$6.29$23,779.87
19th August 2020Ron Bentsur6,533Open or private sale$6.32$41,265.69
18th August 2020Ron Bentsur4,578Open or private sale$5.83$26,691.11
17th August 2020Ron Bentsur4,413Open or private sale$5.72$25,226.03
Stemline Therapeutics
Stemline Therapeutics logo

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.

Ticker: STML
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1264587
Employees: 100
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags